Segments

in CHF m

 

Care Chemicals

 

Catalysis

 

Natural Resources

 

Plastics & Coatings

 

Corporate

 

Total Group

 

 

2018

 

2017

 

2018

 

2017

 

2018

 

2017

 

2018

 

2017

 

2018

 

2017

 

2018

 

2017

1

EBITDA is earning before interest, tax, depreciation and amortization.

2

Not including the result of the partial disposal and revaluation of the participation in Stahl.

3

Includes the effect of the partial disposal and revaluation of the participation in Stahl in the amount of CHF 59 million. The allocation to the Business Areas is as follows: CHF 15 million to Care Chemicals, CHF 8 million to Catalysis, CHF 13 million to Natural Resources and CHF 23 million to Plastics & Coatings.

Segment sales

 

1 681

 

1 589

 

862

 

767

 

1 403

 

1 364

 

2 736

 

2 709

 

 

 

6 682

 

6 429

Sales to other segments

 

–16

 

–14

 

–1

 

 

–9

 

–7

 

–33

 

–31

 

 

 

–59

 

–52

Total sales

 

1 665

 

1 575

 

861

 

767

 

1 394

 

1 357

 

2 703

 

2 678

 

 

 

6 623

 

6 377

Operating expenses

 

–1 414

 

–1 375

 

–750

 

–639

 

–1 298

 

–1 223

 

–2 375

 

–2 381

 

–240

 

–263

 

–6 077

 

–5 881

Thereof:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from associates and joint ventures3

 

29

 

10

 

17

 

11

 

16

 

5

 

54

 

30

 

14

 

47

 

130

 

103

Gain/loss from disposals not qualifying as discontinued operations

 

 

 

 

 

 

 

 

1

 

–54

 

2

 

–54

 

3

Restructuring, impairment and transaction-related costs

 

–2

 

–30

 

–14

 

–7

 

–22

 

–14

 

–4

 

–14

 

–51

 

–115

 

–93

 

–180

Operating income

 

251

 

200

 

111

 

128

 

96

 

134

 

328

 

297

 

–240

 

–263

 

546

 

496

Net financial expenses and taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–190

 

–194

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

356

 

302

Segment assets

 

1 158

 

1 160

 

1 724

 

1 780

 

1 228

 

1 298

 

1 746

 

1 798

 

 

 

 

 

5 856

 

6 036

Segment liabilities

 

–252

 

–244

 

–159

 

–90

 

–159

 

–150

 

–282

 

–273

 

 

 

 

 

–852

 

–757

Net operating assets

 

906

 

916

 

1 565

 

1 690

 

1 069

 

1 148

 

1 464

 

1 525

 

 

 

5 004

 

5 279

Net assets held for sale

 

7

 

10

 

5

 

5

 

 

4

 

2

 

2

 

1

 

1

 

15

 

22

Corporate assets without cash

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 244

 

1 416

 

1 244

 

1 416

Corporate liabilities without financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–1 919

 

–2 239

 

–1 919

 

–2 239

Net debt see note 18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–1 374

 

–1 539

 

–1 374

 

–1 539

Total net assets

 

913

 

926

 

1 570

 

1 695

 

1 069

 

1 152

 

1 466

 

1 527

 

–2 048

 

–2 361

 

2 970

 

2 939

Thereof:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in PPE and intangibles for the period

 

61

 

61

 

56

 

36

 

42

 

49

 

75

 

86

 

23

 

47

 

257

 

279

Investments in associates and joint ventures at the end of the period

 

87

 

64

 

118

 

121

 

9

 

9

 

151

 

154

 

3

 

160

 

368

 

508

Reconciliation of key figures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

251

 

200

 

111

 

128

 

96

 

134

 

328

 

297

 

–240

 

–263

 

546

 

496

Add: systematic depreciation of PPE

 

56

 

54

 

55

 

41

 

38

 

36

 

66

 

68

 

30

 

32

 

245

 

231

Add: impairment

 

 

 

 

1

 

 

1

 

 

12

 

 

2

 

 

16

Add: amortization of intangible assets

 

7

 

6

 

19

 

22

 

23

 

23

 

14

 

10

 

17

 

9

 

80

 

70

EBITDA1

 

314

 

260

 

185

 

192

 

157

 

194

 

408

 

387

 

–193

 

–220

 

871

 

813

Add: restructuring, impairment and transaction-related costs

 

2

 

30

 

14

 

7

 

22

 

14

 

4

 

14

 

51

 

115

 

93

 

180

Less: impairment

 

 

 

 

–1

 

 

–1

 

 

–12

 

 

–2

 

 

–16

Less: gain/loss from disposals not qualifying as discontinued operations2

 

 

 

 

 

 

 

 

–1

 

54

 

–2

 

54

 

–3

Adjusted EBITDA

 

316

 

290

 

199

 

198

 

179

 

207

 

412

 

388

 

–88

 

–109

 

1 018

 

974

Operating income

 

251

 

200

 

111

 

128

 

96

 

134

 

328

 

297

 

–240

 

–263

 

546

 

496

Add: restructuring, impairment and transaction-related costs

 

2

 

30

 

14

 

7

 

22

 

14

 

4

 

14

 

51

 

115

 

93

 

180

Less: gain/loss from disposals not qualifying as discontinued operations

 

 

 

 

 

 

 

 

–1

 

54

 

–2

 

54

 

–3

Adjusted operating income

 

253

 

230

 

125

 

135

 

118

 

148

 

332

 

310

 

–135

 

–150

 

693

 

673